Karen Bracken
About
Karen Bracken is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and General Health Professions.
According to data from OpenAlex, Karen Bracken has authored 26 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Pharmacology and 6 papers in General Health Professions. Recurrent topics in Karen Bracken's work include Hormonal and reproductive studies (11 papers), Pharmacology and Obesity Treatment (7 papers) and Muscle metabolism and nutrition (4 papers). Karen Bracken is often cited by papers focused on Hormonal and reproductive studies (11 papers), Pharmacology and Obesity Treatment (7 papers) and Muscle metabolism and nutrition (4 papers). Karen Bracken collaborates with scholars based in Australia, United States and United Kingdom. Karen Bracken's co-authors include Gary Wittert, Warrick J. Inder, Bronwyn Stuckey, David J. Handelsman, Bu B. Yeap, Mathis Grossmann, Anthony Keech, Wendy Hague, Kristy Robledo and David Jesudason and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.
In The Last Decade
Karen Bracken
25 papers receiving 425 citations
Hit Papers
Peers
Karen Bracken
David Moeny United States
Elise Forbes Australia
Xavier Badía Spain
Maithili N. Davda United States
Jinous Samavat Italy
Bledar Daka Sweden
Torkel Vikan Norway
Herbert I. Rettinger United States
María Molina‐Vega Spain
Rudy M. Haddad United States
Citations per year, relative to Karen Bracken Karen Bracken (= 1×)
peers
David Moeny
Countries citing papers authored by Karen Bracken
Since
Specialization
Citations
This map shows the geographic impact of Karen Bracken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Bracken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Bracken more than expected).
Fields of papers citing papers by Karen Bracken
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Karen Bracken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Bracken. The network helps show where Karen Bracken may publish in the future.
Co-authorship network of co-authors of Karen Bracken
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Bracken. A scholar is included among the top collaborators of Karen Bracken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Bracken. Karen Bracken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Duong, Vicky, Jillian Eyles, Jocelyn L. Bowden, et al.. (2025). DEVELOPMENT AND FEASIBILITY OF THE “OA COACH” MOBILE APPLICATION TO SUPPORT OSTEOARTHRITIS MANAGEMENT. Osteoarthritis and Cartilage. 33. S179–S179.
2.
Bracken, Karen, Robin Christensen, Leticia A. Deveza, et al.. (2024). Efficacy and safety of an oral complementary medicine combination in people with symptomatic knee osteoarthritis: Protocol for the double-blind, randomized, placebo-controlled ATLAS trial. SHILAP Revista de lepidopterología. 6(4). 100522–100522.
3.
Siddiq, Md Abu Bakar, Xiaoqian Liu, Karen Bracken, et al.. (2024). Efficacy and safety of pentosan polysulfate sodium in people with symptomatic knee osteoarthritis and dyslipidaemia: protocol of the MaRVeL trial. BMJ Open. 14(5). e083046–e083046.
4.
Bracken, Karen, et al.. (2024). The use of linked administrative data in Australian randomised controlled trials: A scoping review. Clinical Trials. 21(4). 516–525.
5.
Grossmann, Mathis, Kristy Robledo, Mark Daniel, et al.. (2024). Testosterone Treatment, Weight Loss, and Health-related Quality of Life and Psychosocial Function in Men: A 2-year Randomized Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 109(8). 2019–2028.
6.
Hersch, Jolyn, et al.. (2024). Using the Behaviour Change Wheel to identify barriers and targeted strategies to improve adherence in randomised clinical trials: The example of MEL-SELF trial of patient-led surveillance for melanoma. Contemporary Clinical Trials. 140. 107513–107513.
7.
Robledo, Kristy, Ian C. Marschner, Mathis Grossmann, et al.. (2024). Predicting type 2 diabetes and testosterone effects in high-risk Australian men: development and external validation of a 2-year risk model. European Journal of Endocrinology. 192(1). 15–24.
8.
Robledo, Kristy, Ian C. Marschner, David J. Handelsman, et al.. (2023). Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial. European Journal of Endocrinology. 189(1). 50–57.
9.
Handelsman, David J., Mathis Grossmann, Bu B. Yeap, et al.. (2023). Long-term Outcomes of Testosterone Treatment in Men: A T4DM Postrandomization Observational Follow-up Study. The Journal of Clinical Endocrinology & Metabolism. 109(1). e25–e31.
10.
Bracken, Karen, et al.. (2023). Strategies to Improve Adherence to Skin Self-examination and Other Self-management Practices in People at High Risk of Melanoma. JAMA Dermatology. 159(4). 432–432.
11.
Handelsman, David J., Reena Desai, Ann J. Conway, et al.. (2022). Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections. UWA Profiles and Research Repository (University of Western Australia).
12.
Fui, Mark Ng Tang, Rudolf Hoermann, Karen Bracken, et al.. (2021). Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: A 2-Year RCT. The Journal of Clinical Endocrinology & Metabolism. 106(8). e3143–e3158.
13.
Wittert, Gary, Karen Bracken, Kristy Robledo, et al.. (2020). Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. The Lancet Diabetes & Endocrinology. 9(1). 32–45.
14.
Niazi, Tamim, Scott Williams, Ian D. Davis, et al.. (2020). DASL-HiCAP (ANZUP1801): The impact of darolutamide on standard therapy for localized very high-risk cancer of the prostate—A randomized phase III double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation in very high-risk, clinically localized prostate cancer.. Journal of Clinical Oncology. 38(6_suppl). TPS385–TPS385.
15.
Wittert, Gary, Kristy Robledo, Mathis Grossmann, et al.. (2020). 274-OR: Effect of Testosterone Treatment on Type 2 Diabetes Incidence in High-Risk Men Enrolled in a Lifestyle Program: A Two-Year Randomized Placebo-Controlled Trial. Diabetes. 69(Supplement_1).
16.
Bracken, Karen, Anthony Keech, Wendy Hague, et al.. (2019). A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trial. Clinical Trials. 16(6). 589–598.
17.
Bracken, Karen, Lisa Askie, Anthony Keech, Wendy Hague, & Gary Wittert. (2019). Recruitment strategies in randomised controlled trials of men aged 50 years and older: a systematic review. BMJ Open. 9(4). e025580–e025580.
18.
Bracken, Karen, Wendy Hague, Anthony Keech, et al.. (2019). Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategies. Trials. 20(1). 366–366.
19.
Bracken, Karen, Anthony Keech, Wendy Hague, et al.. (2019). Telephone call reminders did not increase screening uptake more than SMS reminders: a recruitment study within a trial. Journal of Clinical Epidemiology. 112. 45–52.
20.
Bracken, Karen, et al.. (1984). Prostaglandin E<sub>1</sub>Treatment in Experimental Acute Pancreatitis in the Rat. European Surgical Research. 16(5). 265–273.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by David Moeny Breakdown of academic impact, for papers by Elise Forbes Breakdown of academic impact, for papers by Xavier Badía Breakdown of academic impact, for papers by Maithili N. Davda Breakdown of academic impact, for papers by Jinous Samavat Breakdown of academic impact, for papers by Bledar Daka Breakdown of academic impact, for papers by Torkel Vikan Breakdown of academic impact, for papers by Herbert I. Rettinger Breakdown of academic impact, for papers by María Molina‐Vega Breakdown of academic impact, for papers by Rudy M. Haddad